Babler Martin
SEC insider (Form 3/4/5 filer). CIK 0001435618. Director at MapLight Therapeutics, Inc. (MPLT) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in WILMINGTON, DE.
Companies Babler Martin has filed insider reports for
- MapLight Therapeutics, Inc. (MPLT): Director
- Prelude Therapeutics Inc (PRLD): Director
- ALUMIS INC. (ALMS): Director, Officer, President, CEO and Chairman
- 89bio, Inc. (ETNB): Director
Babler Martin
CIK: 0001435618
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 23, 2026MPLT
MapLight Therapeutics, Inc.
AwardDirect7.9K shares- - Jun 9, 2026PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
38K shares- - Jan 26, 2026ALMS
ALUMIS INC.
AwardDirectStock Option (Right to Buy)
745.9K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
56.4K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
67.7K shares- - Jul 29, 2025ALMS
ALUMIS INC.
AwardDirectStock Option (Right to Buy)
150K shares- - Jul 29, 2025ALMS
ALUMIS INC.
AwardDirectStock Option (Right to Buy)
662K shares- - Jun 12, 2025PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
38K shares- - Apr 1, 2025ALMS
ALUMIS INC.
PurchaseIndirect15.7K shares at avg. $6.44$101K - Feb 18, 2025ALMS
ALUMIS INC.
AwardDirectStock Option (Right to Buy)
523K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  MPLT MapLight Therapeutics, Inc. | Award | 7,864 | - | $0 | Direct |
| Jun 9, 2026 |  PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Jan 26, 2026 |  ALMS ALUMIS INC. | Award Stock Option (Right to Buy) | 745,875 | - | - | Direct |
| Oct 30, 2025 |  ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 56,400 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 67,700 | - | - | Direct |
| Jul 29, 2025 | ALMS ALUMIS INC. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| Jul 29, 2025 | ALMS ALUMIS INC. | Award Stock Option (Right to Buy) | 662,000 | - | - | Direct |
| Jun 12, 2025 | PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Apr 1, 2025 | ALMS ALUMIS INC. | Purchase | 15,650 | $6.44 | $100,733 | Indirect |
| Feb 18, 2025 | ALMS ALUMIS INC. | Award Stock Option (Right to Buy) | 523,000 | - | - | Direct |
1-10 of 11 transactions